|
|
 |
|
Viewing report
|
|
|
U.S. Glaucoma Pharmaceuticals Markets
Frost & Sullivan, Feb 1999
As the number of elderly in the United States continues to rise, so will the need for effective glaucoma treatment. This Frost & Sullivan report which resulted from 100 interviews of providers, manufacturers, and industry associations analyzes the markets for pilocarpine, adrenergic agonist, beta-blocking, carbonic anhydrase inhibitor, and prostaglandin drugs. By presenting market statistics and by evaluating market trends, this report offers readers a detailed guide to the industry. It examines R& D trends, identifies potential growth areas, and includes profiles of key industry participants.
|
|
|
|
